Summary & Overview
CPT 0601U: Synovasure Comprehensive PJI Test Panel
CPT code 0601U designates the Synovasure® Comprehensive PJI Test Panel with SynTuition™ — a proprietary laboratory diagnostic that assesses synovial fluid from around joint implants to evaluate for periprosthetic joint infection (PJI). The panel measures 11 biomarkers using immunoassays, hematology, and clinical chemistry methods, then integrates results into an algorithm that provides a probability score for infection. As a PLA code, 0601U applies to a single manufacturer-specific test and is important for coding clarity and payer adjudication of specialized infectious disease diagnostics.
Key payers addressed in this review include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a national-level overview of clinical use and coding implications for this PLA test, plus benchmarking context where available. The publication outlines how the assay is typically used in the diagnostic pathway for suspected PJI, expected sites of service, and what to expect in payer coverage conversations for proprietary lab tests.
This summary is intended to inform billing staff, clinical laboratory managers, and policy analysts about the clinical role of CPT code 0601U, common operational settings for its use, and the payer landscape relevant to adoption and claims processing.
Billing Code Overview
CPT code 0601U is a Proprietary Laboratory Analyses (PLA) code assigned to the Synovasure® Comprehensive PJI Test Panel with SynTuition™ from CD Laboratories Inc., a division of Zimmer Biomet. The test evaluates synovial fluid collected from around a joint implant to assess for periprosthetic joint infection (PJI) by measuring 11 biomarkers and combining those results into a diagnostic algorithm that reports a probability score for infection.
Service type: Laboratory diagnostic test (Proprietary/PLA molecular and immunoassay panel)
Typical site of service: Clinical laboratory or hospital laboratory receiving synovial fluid specimens from outpatient clinics, ambulatory surgery centers, or inpatient surgical services
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a painful, swollen total knee arthroplasty presents to an orthopedic clinic with progressive joint pain, decreased range of motion, and low-grade fever 6 months after implantation. The orthopedic surgeon aspirates synovial fluid from the prosthetic joint in the clinic or procedure suite. Synovial fluid is sent to the laboratory for the proprietary Synovasure® Comprehensive PJI Test Panel with SynTuition™ (0601U). The lab performs immunoassays, hematology, and clinical chemistry on the fluid, measuring 11 biomarkers; the results are processed through the manufacturer’s diagnostic algorithm to produce a probability score for periprosthetic joint infection (PJI). Results inform the clinical team’s decision-making about need for further microbiologic culture, imaging, surgical debridement, staged revision, or targeted antimicrobial therapy. Typical sites of service include outpatient orthopedic clinics, ambulatory procedure suites, hospital inpatient floors, and hospital outpatient departments where joint aspiration and specimen collection occur.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When reporting only the professional component of a separate diagnostic interpretation associated with this laboratory test, if applicable. |